DCN and breast carcinoma: Given the role of the stroma in breast cancer [1,2], the occurrence of genetic alterations in the stroma of breast tumors [13-15] and the putative contribution of decorin and lumican to this disease [10,11], we hypothesized, a priori, that common genetic variation in the DCN and LUM genes is associated with breast cancer risk.